The United Laboratories International Holdings Limited
Research The United Laboratories International Holdings Limited (UNJ) on Bullrun: market cap EUR 1.77B, P/E 6.4, dividend yield 5.8%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerUNJ
- ExchangeF
- CountryHong Kong
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyEUR
- Market capEUR 1.77B
- P/E6.4
- Dividend yield5.8%
- Financial periodFY2025
- RevenueEUR 13.21B
- Revenue growth-4.0%
- Net incomeEUR 2.09B
- Free cash flowEUR 855.45M
- Gross margin41.7%
Valuation Snapshot
latest market cap is EUR 1.77B; P/E is 6.4; dividend yield is 5.8%.
About The United Laboratories International Holdings Limited
The United Laboratories International Holdings Limited, an investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers amoxicillin products; insulin series, antibiotics, and ophthalmic products; and veterinary drugs. It also provides 6-aminopenicillanic acid and penicillin G potassium products.
Frequently asked questions
What is The United Laboratories International Holdings Limited's market cap?
The United Laboratories International Holdings Limited's market capitalization is EUR 1.77B.
What is The United Laboratories International Holdings Limited's P/E ratio?
The United Laboratories International Holdings Limited's price-to-earnings (P/E) ratio is 6.4.
Does The United Laboratories International Holdings Limited pay a dividend?
The United Laboratories International Holdings Limited has a dividend yield of 5.8%.
What does The United Laboratories International Holdings Limited do?
The United Laboratories International Holdings Limited, an investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products.